This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) shed 7.29% to $1.78 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.88% to 22,273.08 and the Dow Jones Industrial Average  rising 1.08% to 46,245.41.
The stock's fall snapped a three-day winning streak.
TherapeuticsMD Inc. closed 27.05% short of its 52-week high of $2.44, which the company achieved on January 3rd.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) rose 2.98% to $236.28.
Trading volume (137,173) remained 131,296 below its 50-day average volume of 268,469.
Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-21-25 1729ET

ABBV

<p>TherapeuticsMD Inc. (TXMD) stock fell 7.29% to $1.78 on Friday, underperforming compared to competitors like AbbVie Inc. (ABBV), which rose 2.98%. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains. TXMD's trading volume was significantly below its 50-day average, and the stock is 27.05% short of its 52-week high.</p>

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors